Wei Wang

Research Associate Professor

PHARMACOLOGICAL AND PHARMACEUTICAL SCIENCES

Health 2 Room 7040

Faculty Bio

Molecular targeting for cancer therapy, development experimental therapeutic agents and evaluation of their mechanism(s) of action, toxicity, and pharmacokinetics, especially for breast cancer treatment.

News

Discovery and Optimization of Small Molecule Drug Leads and Probes

The UH Drug Discovery Institute hosts John Buolamwini of Rosalind Franklin University.

March 24, 2024

A New Generation of Tubulin Inhibitors

Wei Li of the University of Tennessee Health Science Center demonstrates promising research on tubulin inhibitors for metastatic cancer.

June 6, 2023